$2.47T
Total marketcap
$79.56B
Total volume
BTC 50.57%     ETH 14.98%
Dominance

RBC Life Sciences RBCL Stock

0.0001 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
126.14K USD
LOW - HIGH [24H]
0.0001 - 0.0001 USD
VOLUME [24H]
10K USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

RBC Life Sciences Price Chart

RBC Life Sciences RBCL Financial and Trading Overview

RBC Life Sciences stock price 0.0001 USD
Previous Close 0.0003 USD
Open 0.0003 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.0003 - 0.0003 USD
52 Week Range 0.0003 - 0.01 USD
Volume 100 USD
Avg. Volume 1 USD
Market Cap 126.14K USD
Beta (5Y Monthly) -10.360915
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

RBCL Valuation Measures

Enterprise Value -2090786 USD
Trailing P/E N/A
Forward P/E 0.00014084506
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.005230645
Price/Book (mrq) 8.255366E-5
Enterprise Value/Revenue -0.087
Enterprise Value/EBITDA 1.165

Trading Information

RBC Life Sciences Stock Price History

Beta (5Y Monthly) -10.360915
52-Week Change -39.99%
S&P500 52-Week Change 20.43%
52 Week High 0.01 USD
52 Week Low 0.0003 USD
50-Day Moving Average 0.01 USD
200-Day Moving Average 0.01 USD

RBCL Share Statistics

Avg. Volume (3 month) 1 USD
Avg. Daily Volume (10-Days) 10 USD
Shares Outstanding 2.21M
Float N/A
Short Ratio N/A
% Held by Insiders 8.31%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 50:500

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2014
Most Recent Quarter (mrq) September 30, 2015
Next Fiscal Year End December 31, 2015

Profitability

Profit Margin -2.31%
Operating Margin (ttm) -9.59%
Gross Margin 56.90%
EBITDA Margin -7.43%

Management Effectiveness

Return on Assets (ttm) -10.035%
Return on Equity (ttm) -6.77%

Income Statement

Revenue (ttm) 24.12M USD
Revenue Per Share (ttm) 10.9 USD
Quarterly Revenue Growth (yoy) -28.10%
Gross Profit (ttm) 15.64M USD
EBITDA -1794131 USD
Net Income Avi to Common (ttm) -559508 USD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 2.09M USD
Total Cash Per Share (mrq) 0.95 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 2.16
Book Value Per Share (mrq) 3.634

Cash Flow Statement

Operating Cash Flow (ttm) -2903004 USD
Levered Free Cash Flow (ttm) -2585901 USD

Profile of RBC Life Sciences

Country United States
State TX
City Irving
Address 2301 Crown Court
ZIP 75038
Phone 972 893 4000
Website https://www.rbclifesciences.com
Industry Household & Personal Products
Sector(s) Consumer Defensive
Full Time Employees 89

RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products in North America, Southeast Asia, and Australia. The company's Nutritional Products segment offers nutritional supplements and personal care products, including herbs, vitamins, and minerals; and natural skin, hair, and body care products through a network of independent distributors and license arrangements. Its products include Stem-Kine, a dietary supplement; Microhydrin and Microhydrin Plus antioxidants; VitAloe, a blend of research-backed ingredients; OliViva, an antioxidant beverage to support immune and cardiovascular system; Organic Spirulina, a nutritious alga that provides range of nutrients and easily digested proteins; and NeuroBright to support brain function, and enhance energy and acuity. This segments products also comprise Colo-Vada Plus, a colon cleansing program; HydraCel to enhance the quality of drinking water; 24 Seven, a multivitamin/mineral supplement; Immune 360 to nourish and support the function of the immune system; and Aloe Gelee gel that provides the soothing and moisturizing. Its Medical Products segment offers wound care products for the treatment and healing of wounds, such as pressure ulcers, leg ulcers, cuts, burns, and abrasions. Its products include cleansers, dressings, hydrogels, collagen, calcium alginates, moisture barriers, antimicrobials, and a hydrogel wound dressing with Lidocaine. This segment also offers other wound care products designed to reduce destruction to skin and tissue caused by radiation; and to reduce pain and itching in the skin, and the internal mucosa caused by radiation reactions or reactions to various cancer medications. This segment sells its products under the MPM Medical brand to hospitals, nursing homes, clinics, and pharmacies through a network of medical/surgical supply dealers and pharmaceutical distributors. The company was founded in 1988 and is headquartered in Irving, Texas.

Q&A For RBC Life Sciences Stock

What is a current RBCL stock price?

RBC Life Sciences RBCL stock price today per share is 0.0001 USD.

How to purchase RBC Life Sciences stock?

You can buy RBCL shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for RBC Life Sciences?

The stock symbol or ticker of RBC Life Sciences is RBCL.

Which industry does the RBC Life Sciences company belong to?

The RBC Life Sciences industry is Household & Personal Products.

How many shares does RBC Life Sciences have in circulation?

The max supply of RBC Life Sciences shares is 1.26B.

What is RBC Life Sciences Price to Earnings Ratio (PE Ratio)?

RBC Life Sciences PE Ratio is now.

What was RBC Life Sciences earnings per share over the trailing 12 months (TTM)?

RBC Life Sciences EPS is 0 USD over the trailing 12 months.

Which sector does the RBC Life Sciences company belong to?

The RBC Life Sciences sector is Consumer Defensive.